Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease

Co-planar stereotaxic atlas of the human brain : 3-dimensional proportional system : an approach to cerebral imaging

Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058 · see citing works

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C. E., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,417 · see citing works

A polymorphic DNA marker genetically linked to Huntington's disease

Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340 · see citing works

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Hamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,368 · see citing works

Noninvasive determination of local cerebral metabolic rate of glucose in man

Huang, S. C., Phelps, M. E., Hoffman, E. J., Sideris, K., Selin, C. J., & Kuhl, D. E. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.1.e69 · Cited by 926 · see citing works

Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ 18 F]Fluorodeoxyglucose and [ 11 C]Deoxyglucose

Reivich, M., Alavi, A. A., Wolf, A. P., Fowler, J. S., Russell, J. A. G., Arnett, C. D., MacGregor, R. R., Shiue, C., Atkins, H. L., Anand, A., et al. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.24 · Cited by 415 · see citing works

Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease

Mazziotta, J. C., Phelps, M. E., Pahl, J. J., Huang, S., Baxter, L. R., Riege, W. H., Hoffman, J. M., Kuhl, D. E., Lanto, A. B., Wapenski, J. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160701 · Cited by 314 · see citing works

CORTICAL AND SUBCORTICAL GLUCOSE CONSUMPTION MEASURED BY PET IN PATIENTS WITH HUNTINGTON'S DISEASE

Kuwert, T., Lange, H. W., Langen, K., Herzog, H. R., Aulich, A., & Feinendegen, L. E. (1990) · Brain · doi:10.1093/brain/113.5.1405 · Cited by 274 · see citing works

Clinical and neuropathologic assessment of severity in Huntington's disease

Myers, R. H., Vonsattel, J. P., Stevens, T. J., Cupples, L. A., Richardson, E. P., Martin, J. B., & Bird, E. D. (1988) · Neurology · doi:10.1212/wnl.38.3.341 · Cited by 217 · see citing works

Abnormal ocular motor control in Huntington's disease

Leigh, R. J., Newman, S. A., Folstein, S. E., Lasker, A. G., & Jensen, B. A. (1983) · Neurology · doi:10.1212/wnl.33.10.1268 · Cited by 216 · see citing works

Huntington disease: genetics and epidemiology.

Conneally, P. M. (1984) · PubMed · Cited by 202 · see citing works

Performance Characteristics of an Eight-Ring Whole Body PET Scanner

Kops, E. R., Herzog, H. R., Schmid, A., Holte, S., & Feinendegen, L. E. (1990) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199005000-00022 · Cited by 194 · see citing works

Huntington's disease in Venezuela

Young, A. B., Shoulson, I., Penney, J. B., Starosta‐Rubinstein, S., Gomez, F., Travers, H., Ramos-Arroyo, M. A., Snodgrass, S. R., Bonilla, E., Moreno, H., et al. (1986) · Neurology · doi:10.1212/wnl.36.2.244 · Cited by 179 · see citing works

Lehrbuch der Statistik

Bortz, J. (1985) · Springer eBooks · doi:10.1007/978-3-662-08342-0 · Cited by 163 · see citing works

The measurement of abnormal movement: methods developed for Huntington's disease.

Folstein, S. E., Jensen, B. A., Leigh, R. J., & Folstein, M. F. (1983) · PubMed · Cited by 148 · see citing works

IMPAIRMENT OF RAPID MOVEMENT IN HUNTINGTON'S DISEASE

Hefter, H., Hömberg, V., Lange, H. W., & Freund, H. (1987) · Brain · doi:10.1093/brain/110.3.585 · Cited by 143 · see citing works

Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration

Volder, A. D., Francart, J., Laterre, C., Dooms, G., Bol, A., Michel, C. J., & Goffinet, A. M. (1989) · Annals of Neurology · doi:10.1002/ana.410260210 · Cited by 115 · see citing works

A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease

Grafton, S. T., Mazziotta, J. C., Pahl, J. J., George‐Hyslop, P. S., Haines, J. L., Gusella, J. F., Hoffman, J. M., Baxter, L. R., & Phelps, M. E. (1990) · Annals of Neurology · doi:10.1002/ana.410280503 · Cited by 110 · see citing works

Saccades in Huntington's disease

Lasker, A. G., Zee, D. S., Hain, T. C., Folstein, S. E., & Singer, H. S. (1988) · Neurology · doi:10.1212/wnl.38.3.427 · Cited by 109 · see citing works

The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease

Hayden, M. R., Hewitt, J., Stoessl, A. J., Clark, C., Ammann, W., & Martin, W. R. W. (1987) · Neurology · doi:10.1212/wnl.37.9.1441 · Cited by 107 · see citing works

Wilson's disease studied with FDG and positron emission tomography

Hawkins, R. A., Mazziotta, J. C., & Phelps, M. E. (1987) · Neurology · doi:10.1212/wnl.37.11.1707 · Cited by 101 · see citing works

Cortical glucose metabolism in Huntington's disease

Martin, W. R. W., Clark, C. C., Ammann, W., Stoessl, A. J., Shtybel, W., & Hayden, M. R. (1992) · Neurology · doi:10.1212/wnl.42.1.223 · Cited by 100 · see citing works

Event-related potentials in patients with Huntington's disease and relatives at risk in relation to detailed psychometry

Hömberg, V., Hefter, H., Granseyer, G., Strauß, W. H., Lange, H., & Hennerici, M. G. (1986) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(86)90143-4 · Cited by 91 · see citing works

Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's Disease

Young, A. B., Penney, J. B., Starosta‐Rubinstein, S., Markel, D. S., Berent, S., Rothley, J., Betley, A. T., & Hichwa, R. D. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520150010010 · Cited by 88 · see citing works

Lehrbuch der Statistik : für Sozialwissenschaftler

Bortz, J. (1977) · Springer eBooks · Cited by 84 · see citing works

Evoked potentials in patients with Huntington's disease and their offspring. I. Somatosensory evoked potentials

Noth, J., Engel, L., Friedemann, H.-H., & Lange, H. W. (1984) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/0168-5597(84)90029-7 · Cited by 83 · see citing works

Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography.

Tyler, J. L., Strother, S. C., Zatorre, R. J., Alivisatos, B., Worsley, K. J., Dikšić, M., & Yamamoto, Y. (1988) · PubMed · Cited by 80 · see citing works

Positron emission tomography in cases of chorea with different underlying diseases.

Hosokawa, S., Ichiya, Y., Kuwabara, Y., Ayabe, Z., Mitsuo, K., Goto, I., & Kato, M. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.10.1284 · Cited by 60 · see citing works

Increased striatal glucose consumption in sydenham's chorea

Weindl, A., Kuwert, T., Leenders, K. L., Poremba, M., von Einsiedel, H. G., Antonini, A., Herzog, H. R., Scholz, D., Feinendegen, L. E., & Conrad, B. (1993) · Movement Disorders · doi:10.1002/mds.870080404 · Cited by 53 · see citing works

Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease

Kuwert, T., Hefter, H., Scholz, D., Milz, M., Wei�, P., Arendt, G., Herzog, H. R., Loken, M. K., Hennerici, M. G., & Feinendegen, L. E. (1992) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00184123 · Cited by 51 · see citing works

Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of huntington's disease

Kuwert, T., Noth, J., Scholz, D., Schwarz, M., Lange, H. W., Töpper, R., Herzog, H. R., Aulich, A., & Feinendegen, L. E. (1993) · Movement Disorders · doi:10.1002/mds.870080118 · Cited by 43 · see citing works

Regional brain glucose metabolism in neuroacanthocytosis

Dubinsky, R., Hallett, M., Levey, R., & Chiro, G. D. (1989) · Neurology · doi:10.1212/wnl.39.9.1253 · Cited by 42 · see citing works

Frontiers in Clinical Neuroscience

Jellinger, K. A. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00903.x · Cited by 41 · see citing works

Paroxysmal kinesigenic choreoathetosis and paroxysmal dystonic choreoathetosis in a patient with familial idiopathic hypoparathyroidism.

Kato, H., Kobayashi, K., KOHARI, S., Okita, N., & Iijima, K. (1987) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.151.233 · Cited by 41 · see citing works

Cerebral metabolism of glucose in benign hereditary chorea

Suchowersky, O., Hayden, M. R., Martin, W. R. W., Stoessl, A. J., Hildebrand, A., & Pate, B. D. (1986) · Movement Disorders · doi:10.1002/mds.870010105 · Cited by 39 · see citing works

Influence of Size of Regions of Interest on PET Evaluation of Caudate Glucose Consumption

Kuwert, T., Ganslandt, T., Jansen, P., Jülicher, F., Lange, H. W., Herzog, H. R., Scholz, D., Aulich, A., & Feinendegen, L. E. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199209000-00022 · Cited by 23 · see citing works

Normal striatal glucose consumption in two patients with benign hereditary chorea as measured by positron emission tomography

Kuwert, T., Lange, H. W., Langen, K., Herzog, H. R., Hefter, H., Aulich, A., & Feinendegen, L. E. (1990) · Journal of Neurology · doi:10.1007/bf00314666 · Cited by 19 · see citing works

Huntington's Disease: Studies with Structural Imaging Techniques and Positron Emission Tomography

Mazziotta, J. C. (1989) · Seminars in Neurology · doi:10.1055/s-2008-1041346 · Cited by 19 · see citing works

the choreometer: An objective test of chorea during voluntary movements

Trzepacz, P. T., & Webb, M. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90210-1 · Cited by 17 · see citing works

On the influence of spatial resolution and of the size and form of regions of interest on the measurement of regional cerebral metabolic rates by positron emission tomography

Kuwert, T., Sures, T., Herzog, H. R., Loken, M. K., Hennerici, M. G., Langen, K., & Feinendegen, L. E. (1992) · Springer eBooks · doi:10.1007/978-3-7091-9209-2_5 · Cited by 13 · see citing works

Effects of varying physical parameters of a PET system on the accuracy of radioactivity quantitation in vivo.

Herzog, H. R., Kops, E. R., Schmid, A., & Le, F. (1991) · PubMed · Cited by 3 · see citing works

Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012 · see citing works

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885 · see citing works

Mitochondrial defect in Huntington's disease caudate nucleus

Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758 · see citing works

Mechanisms of neurodegeneration in Huntington’s disease

Gil‐Mohapel, J., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 480 · see citing works

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice

Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.-J., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536856100 · Cited by 428 · see citing works

Mitochondrial Diseases of the Brain

Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works

Replicating Huntington's disease phenotype in experimental animals

Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413 · see citing works

Onset and rate of striatal atrophy in preclinical Huntington disease

Aylward, E., Sparks, B. F., Field, K. M., Yallapragada, V., Shpritz, B., Rosenblatt, A., Brandt, J., Gourley, L. M., Liang, K., Zhou, H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000132965.14653.d1 · Cited by 400 · see citing works

Motor disorder in Huntington's disease begins as a dysfunction in error feedback control

Smith, M. A., Brandt, J., & Shadmehr, R. (2000) · Nature · doi:10.1038/35000576 · Cited by 352 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Genetics and Neuropathology of Huntington's Disease

Reiner, A. J., Dragatsis, I., & Dietrich, P. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00014-6 · Cited by 262 · see citing works

Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?

Muddapu, V. R., Dharshini, S. A. P., Chakravarthy, V. S., & Gromiha, M. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00213 · Cited by 248 · see citing works

The Energetics of Huntington's Disease

Browne, S. E., & Beal, M. F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014824.04728.dd · Cited by 240 · see citing works

Impaired PGC-1α function in muscle in Huntington's disease

Chaturvedi, R. K., Adhihetty, P. J., Shukla, S., Hennessy, T., Calingasan, N. Y., Yang, L., Starkov, A. A., Kiaei, M., Cannella, M., Sassone, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp243 · Cited by 237 · see citing works

Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression

Mochel, F., Charles, P., Seguin, F., Barritault, J., Coussieu, C., Périn, L., Bouc, Y. L., Gervais, C., Carcelain, G., Vassault, A. J., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000647 · Cited by 235 · see citing works

Energy deficit in Huntington disease: why it matters

Mochel, F., & Haller, R. G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45691 · Cited by 220 · see citing works

Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production

Guidetti, P., Charles, V., Chen, E., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R. M., & Tagle, D. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7626 · Cited by 197 · see citing works

In defence of ferroptosis

Alves, F. M., Lane, D. J. R., Nguyen, T. P. M., Bush, A. I., & Ayton, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02088-5 · Cited by 197 · see citing works

Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease

Martin, B., Golden, E., Carlson, O. D., Pistell, P. J., Zhou, J., Kim, W., Frank, B. P., Thomas, S., Chadwick, W., Greig, N. H., et al. (2008) · Diabetes · doi:10.2337/db08-0799 · Cited by 181 · see citing works

Mitochondria and Huntington's Disease Pathogenesis: Insight from Genetic and Chemical Models

Browne, S. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.018 · Cited by 176 · see citing works

The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease

Lawrence, A. D. (1998) · Brain · doi:10.1093/brain/121.7.1343 · Cited by 170 · see citing works

Huntingtin-deficient zebrafish exhibit defects in iron utilization and development

Lumsden, A. L., Henshall, T. L., Dayan, S., Lardelli, M. T., & Richards, R. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm138 · Cited by 156 · see citing works

Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders

Covarrubias‐Pinto, A., Acuña, A. I., Beltrán, F. A., Torres-Díaz, L., & Castro, M. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226095 · Cited by 140 · see citing works

Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases

Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139 · see citing works

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease

Harris, G. J., Codori, A. M., Lewis, R. F., Schmidt, E. U., Bedi, A., & Brandt, J. (1999) · Brain · doi:10.1093/brain/122.9.1667 · Cited by 139 · see citing works

Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation

Chaturvedi, R. K., Calingasan, N. Y., Yang, L., Hennessey, T., Johri, A., & Beal, M. F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq229 · Cited by 135 · see citing works

A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice

Acuña, A. I., Esparza, M., Kramm, C., Beltrán, F. A., Parra, A. V., Cepeda, C., Toro, C. A., Vidal, R. L., Hetz, C. A., Concha, I. I., et al. (2013) · Nature Communications · doi:10.1038/ncomms3917 · Cited by 115 · see citing works

Triheptanoin improves brain energy metabolism in patients with Huntington disease

Adanyeguh, I. M., Rinaldi, D., Henry, P., Caillet, S., Valabrègue, R., Dürr, A., & Mochel, F. (2015) · Neurology · doi:10.1212/wnl.0000000000001214 · Cited by 104 · see citing works

Disrupted striatal neuron inputs and outputs in Huntington's disease

Reiner, A. J., & Deng, Y. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12844 · Cited by 93 · see citing works

Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation

Fain, J. N. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.145 · Cited by 87 · see citing works

Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain

Roses, A. D. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0161 · Cited by 86 · see citing works

Altered frontostriatal coupling in pre‐manifest Huntington’s disease: effects of increasing cognitive load

Wolf, R. C., Sambataro, F., Vasić, N., Schönfeldt‐Lecuona, C., Ecker, D., & Landwehrmeyer, G. B. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02253.x · Cited by 73 · see citing works

Bioenergetics failure in neurodegenerative diseases: back to the future

Saxena, U. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.664135 · Cited by 67 · see citing works

18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size

Ciarmiello, A., Giovacchini, G., Orobello, S., Bruselli, L., Elifani, F., & Squitieri, F. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2114-z · Cited by 63 · see citing works

Evidence of cortical metabolic dysfunction in early Huntington's disease by single‐photon‐emission computed tomography

Sax, D. S., Powsner, R. A., Kim, A., Tilak, S., Bhatia, R. G., Cupples, L. A., & Myers, R. H. (1996) · Movement Disorders · doi:10.1002/mds.870110612 · Cited by 61 · see citing works

Pathogenic Mechanisms in Huntington's Disease

Jones, L., & Hughes, A. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00015-8 · Cited by 51 · see citing works

Huntington’s disease and striatal signaling

Roze, E. F. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00055 · Cited by 50 · see citing works

Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion

Visnyei, K., Tatsukawa, K. J., Erickson, R. I., Simonian, S., Oknaian, N., Carmichael, S. T., & Kornblum, H. I. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.023 · Cited by 49 · see citing works

Meclizine is neuroprotective in models of Huntington's disease

Gohil, V. M., Offner, N., Walker, J. A., Sheth, S. A., Fossale, E., Gusella, J. F., MacDonald, M. E., Néri, C., & Mootha, V. K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq464 · Cited by 48 · see citing works

Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET

Andrews, T., & Brooks, D. J. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01371-9 · Cited by 48 · see citing works

Mitochondrial matters of the brain: the role in Huntington’s disease

Turner, C., & Schapira, A. H. V. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9290-y · Cited by 44 · see citing works

Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis

Oechsner, M. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.4.517 · Cited by 37 · see citing works

Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

McDonald, T. S., Lerskiatiphanich, T., Woodruff, T. M., McCombe, P., & Lee, J. D. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221135061 · Cited by 35 · see citing works

Neural Transplantation for Huntington's Disease: Experimental Rationale and Recommendations for Clinical Trials

Shannon, K. M., & Kordower, J. H. (1996) · Cell Transplantation · doi:10.1016/0963-6897(95)02052-7 · Cited by 34 · see citing works

Metabolism in Huntington’s disease: a major contributor to pathology

Singh, A., & Agrawal, N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00844-y · Cited by 33 · see citing works

Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients

Chang, K., Chen, Y., Wu, Y., Lee, W.-F., & Chen, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046492 · Cited by 31 · see citing works

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease

for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Agosta, F., Altomare, D., Festari, C., Orini, S., Gandolfo, F., Boccardi, M., Arbizu, J., Bouwman, F. H., Drzezga, A. E., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4033-0 · Cited by 31 · see citing works

Benzodiazepine receptor quantification in Huntington's disease with [123I]iomazenil and SPECT

Pinborg, L. H. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.5.657 · Cited by 24 · see citing works

Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies

Niccolini, F., Pagano, G., Fusar‐Poli, P., Wood, A., Mrzljak, L., Sampaio, C., & Politis, M. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316633 · Cited by 22 · see citing works

The Differential Vulnerability of Striatal Projection Neurons in 3-Nitropropionic Acid-Treated Rats Does Not Match That Typical of Adult-Onset Huntington's Disease

Sun, Z., Xie, J., & Reiner, A. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7947 · Cited by 22 · see citing works

An enquiry to the role of CB1 receptors in neurodegeneration

Fernández‐Moncada, I., Eraso‐Pichot, A., Tor, T. D., Fortunato-Marsol, B., & Marsicano, G. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106235 · Cited by 21 · see citing works

Mitochondrial and metabolic-based protective strategies in Huntington’s disease: the case of creatine and coenzyme Q

Naia, L., Ribeiro, M. J., & Rego, A. C. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.060 · Cited by 19 · see citing works

Bilateral temporal lobe epilepsy confirmed with intracranial EEG in chorea-acanthocytosis

Bader, B., Vollmar, C., Ackl, N., Ebert, A., la Fougère, C., Noachtar, S., & Danek, A. (2011) · Seizure · doi:10.1016/j.seizure.2010.12.007 · Cited by 19 · see citing works

Brain Energy Metabolism in Health and Disease

Felipe, A., Anbal, I., Paz, M., & Maite, A. (2012) · InTech eBooks · doi:10.5772/36092 · Cited by 18 · see citing works

Imaging in cell-based therapy for neurodegenerative diseases

Kirik, D., Breysse, N., Björklund, T., Besret, L., & Hantraye, P. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1909-6 · Cited by 18 · see citing works

Funktionelle Bildgebung kognitiver Prozesse bei M.-Huntington-Patienten und präsymptomatischen Mutationsträgern

Wolf, R. C., Vasić, N., Schönfeldt‐Lecuona, C., Ecker, D., & Landwehrmeyer, G. B. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2390-1 · Cited by 17 · see citing works

Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review

Aqel, S., Ahmad, J., Saleh, I., Fathima, A., Thani, A. A. A., Mohamed, W. M. Y., & Shaito, A. A. (2025) · Biology · doi:10.3390/biology14020129 · Cited by 16 · see citing works

Huntington's disease

Bonelli, R. M., & Beal, M. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00030-9 · Cited by 16 · see citing works

Delayed Onset and Reduced Cognitive Deficits through Pre-Conditioning with 3-Nitropropionic Acid is Dependent on Sex and CAG Repeat Length in the R6/2 Mouse Model of Huntington’s Disease

Skillings, E. A., & Morton, A. J. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160189 · Cited by 14 · see citing works

[18F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review

Timmers, E. R., Klamer, M. R., Marapin, R. S., Lammertsma, A. A., de Jong, B. M., Dierckx, R. A. J. O., & Tijssen, M. A. J. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06110-w · Cited by 12 · see citing works

Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography

Leslie, W. D., Greenberg, C. R., Abrams, D. N., & Hobson, D. E. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050479 · Cited by 11 · see citing works

Impaired intracellular trafficking of sodium‐dependent vitamin C transporter 2 contributes to the redox imbalance in Huntington’s disease

Covarrubias‐Pinto, A., Parra, A. V., Mayorga-Weber, G. A., Papic, E., Vicencio, I., Ehrenfeld, P., Rivera, F. J., & Castro, M. A. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24693 · Cited by 11 · see citing works

Bioenergetic adaptations to HIV infection. Could modulation of energy substrate utilization improve brain health in people living with HIV-1?

Deme, P., Rojas, C. J., Slusher, B. S., Rais, R., Afghah, Z., Geiger, J. D., & Haughey, N. J. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113181 · Cited by 10 · see citing works

Nucleic Acid-Based Therapy Approaches for Huntington's Disease

Vagner, T., Young, D., & Mouravlev, A. (2012) · Neurology Research International · doi:10.1155/2012/358370 · Cited by 8 · see citing works

Arrangement de scripts dans la maladie de Huntington

Allain, P., Verny, C., Aubin, G., Bonneau, D., Dubas, F., & Gall, D. L. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)70925-x · Cited by 8 · see citing works

Sensory processing in Huntington’s disease

Mirallave, A., Morales, M., Cabib, C., Muñoz, E., Santacruz, P., Gasull, X., & Valls‐Solé, J. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.01.009 · Cited by 7 · see citing works

Doença de Huntington

Gil‐Mohapel, J., & Rego, A. C. (2001) · Revista Neurociências · doi:10.34024/rnc.2011.v19.8332 · Cited by 7 · see citing works

Effect of Triheptanoin on Caudate Atrophy and Motor Scores in Patients With Early-Stage Huntington Disease

Mochel, F., Méneret, A., Adanyeguh, I. M., Giron, C., Hainque, É., Luton, M., Atencio, M., Debs, R., Jacobs, M., Veldkamp, F., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000210194 · Cited by 6 · see citing works

Therapeutic strategies in Huntington?s disease

Alberch, J., Canals, J. M., & Pérez‐Navarro, E. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.4.449 · Cited by 4 · see citing works

Mitochondrial Microproteins: Emerging Regulators in Neurodevelopment and Neurodegeneration

Borghol, N., Yandiev, S., & Courchet, J. (2025) · BioEssays · doi:10.1002/bies.70058 · Cited by 3 · see citing works

Early Dysfunction of Neural Transmission and Cognitive Processing in Huntington’s Disease

Michael, I., Steffes-Lovdahl, S. K., Jayaprakash, N., Wolfram-Aduan, A., & Gary, L. (2012) · InTech eBooks · doi:10.5772/30528 · Cited by 3 · see citing works

Magnetic Resonance Spectroscopy in Huntington’s Disease

Mochel, F., Dubinsky, J. M., & Henry, P. (2016) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-33555-1_6 · Cited by 2 · see citing works

Preclinical stages in subjects at risk for neurological disorders: Can PET FDG tell us more?

Azari, N. P., & Pietrini, P. (1995) · Journal of Neurology · doi:10.1007/bf00887827 · Cited by 2 · see citing works

Systemic Administration of 3-Nitropropionic Acid

Brouillet, E., Hantraye, P., & Beal, M. F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_16 · Cited by 2 · see citing works

Replicating Huntington Disease’s Phenotype in Nonhuman Primates

Hantraye, P., Palfi, S., Mittoux, V., Dautry, C., Condé, F., & Brouillet, E. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_17 · Cited by 1 · see citing works

Therapeutic Approach in Huntington's Disease

Dürr, A. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01258-4 · Cited by 1 · see citing works

Cellular and Molecular Mechanisms of Neuronal Dysfunction in Huntington's Disease

Caboche, J., Vanhoutte, P., Boussicault, L., Roze, E. F., & Bétuing, S. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00045-3 · Cited by 1 · see citing works

PET in Huntington’s Disease

Kremer, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_28 · Cited by 1 · see citing works

Disease Modifying Agents for Huntington??s Disease

Clarke, H., & Feigin, A. (1999) · CNS Drugs · doi:10.2165/00023210-199912050-00005 · Cited by 1 · see citing works

The molecular pathogenesis of Huntington’s disease

Turner, C. D. (2009) · UCL Discovery (University College London)

SPECT-Untersuchungen bei degenerativen Krankheiten des Gehirns

Kuwert, T. (1995) · Springer eBooks · doi:10.1007/978-3-642-79222-9_13

PET in Huntington’s Disease

Kremer, H. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_30

Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders

Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306

UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CIÊNCIAS BÁSICAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS

Alegre, P. (2006)

Efeito in vitro de quinureninas sobre parâmetros bioquímicos do metabolismo enrgético em cérebro de ratos jovens

Schuck, P. F. (2005) · Americanae (AECID Library)

Eine epidemiologische Studie im süddeutschen Raum

Rehm, M. M. (2004)

Klinische Relevanz von PET-Untersuchungen in der Neurologie und Psychiatrie

Bartenstein, P. (2004) · Clinical Neuroradiology · doi:10.1007/s00062-004-5381-7

THÉORIE DE L'ESPRIT et LOBE FRONTAL

Doctorale, É. (2007)

Untersuchung des regionalen cerebralen Glukoseverbrauchs mit FDG-PET und des rCBF mit 99mTC-HMPAO-SPECT bei Patienten mit Morbus Huntington: ein Methodenvergleich

Boecker, H., Kuwert, T., Langen, K., Lange, H. W., Czech, N., Ziemons, K., Herzog, H. R., Weindl, A., & Feinendegen, L. E. (1995) · Verhandlungen der Deutschen Gesellschaft für Neurologie · doi:10.1007/978-3-7091-9415-7_107

Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease

Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23

Genetic and degenerative disorders primarily causing other movement disorders

Pavese, N., & Tai, Y. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00025-8

Oxidative Stress and Huntington’s Disease

Turner, C., & Schapira, A. H. V. (2003) · Oxidative stress and disease · doi:10.1201/9780203912874.ch20

Huntington's Disease

Browne, S. E., & Beal, M. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50051-2

Imaging of Cerebral Metabolism in Huntington’s Disease

Kuwert, T. (2003) · Springer eBooks · doi:10.1007/978-3-642-55539-8_19

Déficits développementaux du circuit striatal chez des modèles murins de la maladie de Huntington

Lebouc, M. (2023) · theses.fr (ABES) · doi:10.70675/f136158dz8184z4417z99f6z6f1479f2dcbe

Efeito da administração intraestriatal aguda de ácido quinolínico sobre metabolismo energético em ratos jovens

Ribeiro, C. A. J. (2006) · Americanae (AECID Library)

HMPAO-SPECT and FDG-PET in Huntington’s Disease: A Methodological Study Comparing the Performance of PET with That of a Three Headed SPECT Camera

Weckesser, M., Kuwert, T., Lange, H. W., Boecker, H., Herzog, H. R., Ziemons, K., Langen, K., Feinendegen, L. E., & Müller-Gärtner, H.-W. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7340-6_31

Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of huntington's disease

Kuwert, T., Noth, J., Scholz, D., Schwarz, M., Lange, H. W., Töpper, R., Herzog, H. R., Aulich, A., & Feinendegen, L. E. (1993) · Movement Disorders · doi:10.1002/mds.870080118 · Cited by 43 · see citing works

CORTICAL AND SUBCORTICAL GLUCOSE CONSUMPTION MEASURED BY PET IN PATIENTS WITH HUNTINGTON'S DISEASE

Kuwert, T., Lange, H. W., Langen, K., Herzog, H. R., Aulich, A., & Feinendegen, L. E. (1990) · Brain · doi:10.1093/brain/113.5.1405 · Cited by 274 · see citing works

Normal striatal glucose consumption in two patients with benign hereditary chorea as measured by positron emission tomography

Kuwert, T., Lange, H. W., Langen, K., Herzog, H. R., Hefter, H., Aulich, A., & Feinendegen, L. E. (1990) · Journal of Neurology · doi:10.1007/bf00314666 · Cited by 19 · see citing works

Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease

Mazziotta, J. C., Phelps, M. E., Pahl, J. J., Huang, S., Baxter, L. R., Riege, W. H., Hoffman, J. M., Kuhl, D. E., Lanto, A. B., Wapenski, J. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160701 · Cited by 314 · see citing works

Positron emission tomography in cases of chorea with different underlying diseases.

Hosokawa, S., Ichiya, Y., Kuwabara, Y., Ayabe, Z., Mitsuo, K., Goto, I., & Kato, M. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.10.1284 · Cited by 60 · see citing works